HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
The Gut Microbiome and Diabetes

Growing evidence suggests that the gut microbiome and diabetes are intricately linked, with gut bacteria influencing glucose metabolism, insulin resistance, and inflammation. Dysbiosis, or microbial imbalance, has been associated with an increased risk of type 2 diabetes and metabolic dysfunction. Short-chain fatty acids produced by beneficial bacteria play a role in improving insulin sensitivity and regulating appetite. Probiotics, prebiotics, and dietary interventions targeting gut microbiota composition offer promising therapeutic potential. Advances in metagenomics and microbiome research continue to uncover mechanisms by which gut flora modulate metabolic health. Understanding these interactions may lead to novel microbiome-based strategies for diabetes prevention and treatment.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp